Ginsenosides regulation of lysophosphatidylcholine profiles underlies the mechanism of Shengmai Yin in attenuating atherosclerosis.


Journal

Journal of ethnopharmacology
ISSN: 1872-7573
Titre abrégé: J Ethnopharmacol
Pays: Ireland
ID NLM: 7903310

Informations de publication

Date de publication:
15 Sep 2021
Historique:
received: 15 02 2021
revised: 13 05 2021
accepted: 19 05 2021
pubmed: 28 5 2021
medline: 24 11 2021
entrez: 27 5 2021
Statut: ppublish

Résumé

The traditional Chinese medicine (TCM) preparation, Shengmai Yin (SMY), is widely applied in cardiovascular disease treatments. However, the pharmacological mechanism of its therapeutic effects has not been fully clarified. This study aimed to clearly define the efficacy and underlying mechanism of SMY and its active components in protecting against atherosclerosis. The pharmacological effects of SMY and its components were evaluated upon a mouse hypercholesteremia model induced by a high cholesterol diet (HCD) for 12 weeks and Apoe SMY and red ginseng crude extracts (GE) significantly decreased the serum cholesterol levels in hypercholesteremia mice and reduced the aortic root plaque areas and exerted antiatherogenic efficacy in Apoe Our findings revealed that ginsenosides from SMY exerted therapeutic effects on atherosclerosis by maintaining lipid homeostasis including cholesterol and lysoPCs.

Identifiants

pubmed: 34044080
pii: S0378-8741(21)00450-5
doi: 10.1016/j.jep.2021.114223
pii:
doi:

Substances chimiques

Apolipoproteins E 0
Cholesterol, Dietary 0
Cytokines 0
Drug Combinations 0
Drugs, Chinese Herbal 0
Ginsenosides 0
Lysophosphatidylcholines 0
fructus schizandrae, radix ginseng, radix ophiopogonis drug combination 0
Cholesterol 97C5T2UQ7J

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

114223

Informations de copyright

Copyright © 2021 The Authors. Published by Elsevier B.V. All rights reserved.

Auteurs

Yun Wang (Y)

State Key Laboratory of Natural Medicines, Key Laboratory of Drug Metabolism and Pharmacokinetics, China Pharmaceutical University, Nanjing, China. Electronic address: wy1141213@163.com.

Jiawei Wu (J)

State Key Laboratory of Natural Medicines, Key Laboratory of Drug Metabolism and Pharmacokinetics, China Pharmaceutical University, Nanjing, China. Electronic address: wugewain@163.com.

Jiaying Zhu (J)

State Key Laboratory of Natural Medicines, Key Laboratory of Drug Metabolism and Pharmacokinetics, China Pharmaceutical University, Nanjing, China. Electronic address: 3320071851@stu.cpu.edu.cn.

Chujie Ding (C)

State Key Laboratory of Natural Medicines, Key Laboratory of Drug Metabolism and Pharmacokinetics, China Pharmaceutical University, Nanjing, China. Electronic address: dcj_1994@163.com.

Wanfeng Xu (W)

State Key Laboratory of Natural Medicines, Key Laboratory of Drug Metabolism and Pharmacokinetics, China Pharmaceutical University, Nanjing, China. Electronic address: 15251768808@163.com.

Haiping Hao (H)

State Key Laboratory of Natural Medicines, Key Laboratory of Drug Metabolism and Pharmacokinetics, China Pharmaceutical University, Nanjing, China. Electronic address: haipinghao@cpu.edu.cn.

Jun Zhang (J)

School of Pharmacy, Nanjing Medical University, Nanjing, China. Electronic address: zhangjun@njmu.edu.cn.

Guangji Wang (G)

State Key Laboratory of Natural Medicines, Key Laboratory of Drug Metabolism and Pharmacokinetics, China Pharmaceutical University, Nanjing, China. Electronic address: guangjiwang@hotmail.com.

Lijuan Cao (L)

State Key Laboratory of Natural Medicines, Key Laboratory of Drug Metabolism and Pharmacokinetics, China Pharmaceutical University, Nanjing, China. Electronic address: caolijuan0702@cpu.edu.cn.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH